Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction
Gilles Montalescot(Maastricht University Medical Centre), Leonardo Bolognese(Azienda Usl 8 Arezzo), Andrea Lavoie, Jurriën M. ten Berg(St. Antonius Ziekenhuis), Djamaleddine Nibouche, M.T. Bouafia, Ángel Cequier(Bellvitge University Hospital), Michael Brunner, Franz Weidinger(Austrian Competence Centre of Food Safety), Warren J. Cantor(University of Toronto), Muriel Licour(AstraZeneca (France)), Christopher Hammett(Royal Brisbane and Women's Hospital), Gerhard Prause, Robert F. Storey(University of Sheffield), Johanne Silvain(Sorbonne Université), Stephen Rashford(Queensland Government), Rohan Jayasinghe, Omar Kaid, Mohamed Chettibi(Unknown), Messaad Krim, Dieter Sebald, Frédéric Lapostolle(Délégation Paris 5), Hannes Alber(Klinikum Klagenfurt), Magnus Janzon(Linköping University), R. Bougherbal, Kurt Huber(Sigmund Freud Privatuniversität Wien), Johann Sipoetz(Inserm), Uwe Zeymer(University of Freiburg), Béla Merkely(Semmelweis University), Helmut Brussee, Éric Vicaut(Université Paris Cité), Anne Tsatsaris(AstraZeneca (France)), Arnoud W.J. van ’t Hof(Isala), Jean‐Philippe Collet(Inserm), Thomas Neunteufl, C Hamm(Royal Brisbane and Women's Hospital), Néjoua Salhi(AstraZeneca (United Kingdom)), Ram Vijayaraghavan(The Scarborough Hospital), Michael Baubin, Iqbal Bata, Shaun G. Goodman(St. Michael's Hospital), P. Garrahy, Abdelkader Moklati, Jens Flensted Lassen(University of Southern Denmark), Ahmed Benalia
Cited by 43
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k